ST未名：预计2025年净利润亏损5500万元-9000万元

Core Viewpoint - The company ST Unimed expects a net profit loss of 55 million to 90 million yuan for the fiscal year 2025, compared to a loss of 137 million yuan in the same period last year [1] Group 1: Financial Performance - The anticipated loss for 2025 is primarily due to the suspension of production and sales by its subsidiary, Tianjin Unimed Biopharmaceutical Co., Ltd., which has significantly impacted related business revenue [1] - The company is actively working on rectification to expedite the resumption of production, but ongoing costs and expenses continue to contribute to the losses [1]